|Year : 2021 | Volume
| Issue : 4 | Page : 248-257
Identification and estimation of vicine bioactive compound in Momordica charantia L. fruit and coded Ayurvedic formulation using HPLC method
Ajay Kumar Meena1, Arjun Singh2, Kudingila Narasimha Swathi3, Vikas Ojha1, Amit Kumar Dixit4, Raju Ilavarasan3, Narayanam Srikanth2
1 Regional Ayurveda Research Institute, Gwalior, Madhya Pradesh, India
2 Central Council for Research in Ayurvedic Sciences, New Delhi, India
3 Captain Srinivasa Murthy Central Ayurveda Research Institute, Chennai, Tamil Nadu, India
4 Central Ayurveda Research Institute, Kolkata, West Bengal, India
|Date of Submission||23-Jul-2021|
|Date of Acceptance||20-Jan-2022|
|Date of Web Publication||17-May-2022|
Ajay Kumar Meena
Regional Ayurveda Research Institute, Gwalior, Madhya Pradesh
Source of Support: None, Conflict of Interest: None
BACKGROUND AND OBJECTIVE: Momordica charantia L. is one of the important Ayurvedic drugs having anti-diabetic, anti-viral, anti-ulcerogenic, anti-tumor, immunomodulatory, and anti-lipolytic and hepatoprotective properties. This study was designed for comparative fingerprint profiling of vicine bioactive compound in M. charantia L. fruit extract and coded Ayurvedic formulation extract through high-performance thin layer chromatography (HPTLC) and for developing rapid high-performance liquid chromatography (HPLC) method for the determination of vicine in fruit extract and coded Ayurvedic formulation. MATERIALS AND METHODS: The dried powder of M. charantia L. fruit (10.3448 g) and powder of coded Ayurvedic formulation (13.4975 g) were extracted by using a Soxhlet apparatus for 24 h. For HPTLC finger printing, ethyl acetate: methanol: water: formic acid (7:3:1:0.5; v/v/v/v) was used as a solvent system. The quantitative analysis was performed by HPLC using acetonitrile and water (65:35 v/v) as mobile phase, with 1.0 mL/min flow rate at 275 nm, and the retention time of vicine was 3.688 min. RESULTS AND DISCUSSION: A band was obtained at 254 nm (green, Rf = 0.31) in standard and test solution tracks of M. charantia L. fruit extract and coded Ayurvedic formulation extract corresponding to vicine. The calibration plot showing linear relationship with concentration has been observed. A linear equation is y = 12.224x + 7.829, and the goodness of fit (r2) of 0.99 was obtained from the regression analysis, which showed proportional dependence between concentration and peak area. CONCLUSION: Results of the HPLC analysis showed that the coded Ayurvedic formulation extract and M. charantia L. fruit extract contains 0.0273% and 0.0603% of vicine biomarker compound, respectively.
Keywords: Alkaloid, anti-diabetic, coded Ayurvedic formulation, M. charantia, quantification, vicine
|How to cite this article:|
Meena AK, Singh A, Swathi KN, Ojha V, Dixit AK, Ilavarasan R, Srikanth N. Identification and estimation of vicine bioactive compound in Momordica charantia L. fruit and coded Ayurvedic formulation using HPLC method. J Drug Res Ayurvedic Sci 2021;6:248-57
|How to cite this URL:|
Meena AK, Singh A, Swathi KN, Ojha V, Dixit AK, Ilavarasan R, Srikanth N. Identification and estimation of vicine bioactive compound in Momordica charantia L. fruit and coded Ayurvedic formulation using HPLC method. J Drug Res Ayurvedic Sci [serial online] 2021 [cited 2022 Jun 29];6:248-57. Available from: http://www.jdrasccras.com/text.asp?2021/6/4/248/345394
| Introduction|| |
Momordica charantia L. from Cucurbitaceae family is used as holistic folk medicine in the treatment of various ailments since ages [Figure 1]. Various pharmacological activities of M. charantia L. have been reported showing anti-fertility, anti-diabetes, anti-lipolytic, anti-ulcerogenic, antibacterial, hepatoprotective, anti-tumor, antioxidant, anti-mutagenic, anthelmintic, and anti-inflammatory potentials.,, Cucurbitacins having cucurbitane skeleton are highly oxygenated, triterpenic, tetracyclic, bitter taste plant substances found in Cucurbitaceae family plants. Studies indicated that cucurbitane types are responsible for hypoglycemia and anti-diabetic activities in M. charantia L. Gurmarin, a polypeptide which is present in fruit and leaf of M. charantia L., has similarity with bovine insulin and exhibits sugar-regulating efficacy by modulating neural responses to sweet taste stimuli.
Heteropolysaccharide composed of glucose (Glu), galactose (Gal), rhamnose (Rha), arabinose (Ara), and mannose (Man) forms about 6% powder of bitter gourd. The unsaturated fatty acid content in M. charantia fruit is relatively higher; the ratio of monounsaturated fatty acids to total fatty acids is about 20.1%, and of the total fatty acid, nearly 64.3% is polyunsaturated fatty acid. Catechin, gallic acid, gentisic acid, chlorogenic acid, and epicatechin are important phenolic constituents in the M. charantia L. fruit extracts. Cucurbitane compounds, i.e., momordicosides A, C, F1, I, and K; goyasaponins I, II, and III; goyaglycosides a, b, c, d, e, f, g, and h, were already reported in the methanol extract of M. charantia L. fruits. The vicine content in seeds, leaves, and fruits of M. charantia L. was 0.524%, 0.0456%, and 0.115%, respectively.
Vicine (2,6-diamino-5-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy-1H-pyrimidin-4-one) is an alkaloid glycoside [Figure 2]. Studies reported that this pyrimidine nucleoside induced hypoglycemic effect in non-diabetic fasting rats. Vicine causes hemolytic anemia called favism in people with inborn glucose-6-phosphate dehydrogenase enzyme deficiency.
In this study, we have selected an Ayurvedic coded formulation and M. charantia L. fruit, which is used to maintain diabetes. The selected coded Ayurveda formulation contains M. charantia L. and nearly 11 other plant crude drugs. The literature suggests various analytical methods for isolation and determination of vicine in M. charantia L. and in compound formulation.,, Therefore, in this study, vicine, one of the most important active biomarkers having various physiological actions, was selected for the identification quantification in formulation and its ingredient.
| Materials and Methods|| |
Coded Ayurvedic formulation, its ingredient, and M. charantia L. fruit were provided by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush, Government of India, New Delhi.
The chemicals, reagents, and solvents for the study were procured from E. Merck and of HPLC and AR grade. Bioactive marker was purchased from M/s Natural Remedies, Bengaluru, Karnataka, India.
HPTLC fingerprint profile of vicine in M. charantia L. fruit extract and coded Ayurvedic formulation extract
The dried powder of M. charantia L. fruit (10.3448 g) and coded Ayurvedic formulation (13.4975 g) were extracted separately with water (200 mL) using a Soxhlet apparatus for 24 h, dried under reduced pressure, collected, weighed, and stored for studies. The obtained extracted residual weights of M. charantia L. fruit and coded Ayurvedic formulation were 4.2304 and 3.8044 g, respectively (Residue A and Residue B).,,,
Standard vicine solution has been prepared by dissolving 4.2 mg of vicine standard in 10 mL of HPLC grade water to get a 0.42 mg/mL vicine stock solution.
The test solution for HPTLC analysis and identification of vicine, was prepared by dissolving 50 mg of residue A and residue B in water and filtered by 0.22 μm membrane filters.
Ethyl acetate: methanol: water: formic acid were taken in the ratio of 7:3:1:0.5; v/v/v/v.
An aliquot of 4 µL of coded Ayurvedic formulation extract and M. charantia L. fruit extract and vicine standard solution was applied separately on different tracks of silica gel 60F254-coated TLC plate (0.2 mm thickness) using automatic sample applicator and developed.
Detection and scanning
The TLC plate was observed at UV wavelengths of 254 and 366 nm by TLC visualizer having deuterium and mercury lamps, and photographs were recorded. The plate was again dipped in vanillin-sulfuric acid solution and heated at 105°C using hot air to get color spots and scanned at 540 nm and the photo was documented. WIN CATS software was used for fingerprints data.
Method development and optimization for quantitative estimation using HPLC
About 0.42 mg/mL (see the Standard solution section) vicine stock solution and 0.50 mg/mL (see the Test solution section) sample solution were taken for this analysis. To optimize the chromatographic conditions on a C18 (250 cm × 4.6 mm; 5 μm) column, a series of trails by changing the concentration of acetonitrile and water were performed. Acetonitrile and water buffer in the ratio 65:35 v/v at 1 mL/min flow rate, 10 μL injection volume, 10 min run time, with 30°C column temperature at 275 nm wavelength (λ) and DAD detector was observed to be the best suitable chromatographic condition for this study.,,,
| Results and Discussion|| |
HPTLC fingerprint profiling
Photos of the TLC plate were documented at 254 and 366 nm, after treatment with vanillin-sulfuric acid reagent, and Rf values were calculated [Figure 3] and [Table 2]. The TLC plate was scanned at 254, 366, and 540 nm [Figure 4][Figure 5][Figure 6].
A band at 254 nm (green, Rf = 0.31) corresponding to vicine is found in standard and test solution tracks of M. charantia L. fruit extract and coded Ayurvedic formulation extract, but a band of vicine is not visible in UV at 366 nm and white light.
Quantitative estimation of vicine by HPLC
In the HPLC analysis, vicine was eluted with symmetrical peak at retention time (RT) of about 3.688 min [Figure 7].
|Figure 7: HPLC chromatogram of coded Ayurvedic formulation, Momordica charantia L. fruit, and vicine biomarker compound|
Click here to view
Vicine stock solution (0.42 mg/mL) was diluted to get 0.105, 0.0525, 0.02625, 0.013125, 0.00656 mg/mL concentrations and run through HPLC system. Standard calibration curve was made [Figure 8].
Estimation of vicine
The quantification of vicine in coded Ayurvedic formulation extract and M. charantia L. fruit extract was done using HPLC. Samples and standard showed respective peaks of vicine at the same RT. Coded Ayurvedic formulation extract and M. charantia L. fruit extract were injected (10 μL) to HPLC, and chromatograms were analyzed to get the concentration from the standard calibration curve.
Similar to the vicine standard, the HPLC of M. charantia L. fruit extract and coded Ayurvedic formulation extract was also obtained at an RT of 3.688 min, at 275 nm wavelength. The vicine contents in coded Ayurvedic formulation and M. charantia L. fruit extract were presented in [Figure 7] and [Table 1].
The quantitative evaluation of vicine present in the coded Ayurvedic formulation extract and M. charantia L. fruit extract was 0.0273% and 0.0603%, respectively.
| Conclusion|| |
Identification, separation and estimation of bioactive components in plants material are still considered as strenuous process as plant materials are multi-component mixture of different biomolecules and requires combination of several chromatographic techniques and various other purification methods to isolate. Standardization, optimization, method validation protocol of herbal formulations, and its bioactive constituents are of utmost importance to ensure quality, purity, efficacy, and safety. Presently, in Ayurvedic drug development modern and sophisticated analytical tools like HPLC and HPTLC are equally essential for quality control and quality assurance of the raw drug and formulation. This study showed the presence of vicine biomarker in coded Ayurvedic formulation, which reveals the presence of M. charantia L. in the formulation. Results of the present study have also established a successful HPLC and HPTLC method to identify and estimate vicine biomarker from M. charantia L., which can be conveniently employed for routine quality control analysis of the marker compounds in formulations with this ingredient.
I would like to thank all the people of scientists, New Delhi who contributed in some way to the work described in this study.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia
fruit juice on islet morphology in the pancreas of the streptozitocin-diabetic rat. Diabetes Res Clin Pract 1998;40:145-51.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
Raza H, Ahmed I, John A, Sharma AK. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia
fruit extract. J Biochem Mol Toxicol 2000;14:131-9.
Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX. Cucurbitacins and cucurbitane glycosides: Structures and biological activities. Nat Prod Rep 2005;22:386-99.
Meena AK, Bansal P, Kuma S. Herbal wealth as a potential source of ayurvedic drugs. Asian J Tradition Med 2009;4:51-69.
Dong Y, Xu B, Lu Q, Zha Q. Studies on the isolation, purification and composition of Momordica charantia
L. polysaccharide. Food Sci 2005;11:023.
Kenny O, Smyth TJ, Hewage CM, Brunton NP. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum
) seeds and bitter melon (Momordica charantia
) fruit. Food Chem 2013;141:4295-302.
Horax R, Hettiarachchy N, Chen P. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia
) harvested at three maturity stages (immature, mature, and ripe). J Agric Food Chem 2010;58:4428-33.
Murakami T, Emoto A, Matsuda H, Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, b, c, d, e, f, g, and h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia
L. Chem Pharm Bull 2001;49:54-63.
Joseph B, Jini D. Antidiabetic effects of Momordica charantia
(bitter melon) and its medicinal potency. Asian Pac J Trop Dis 2013;3: 93-102.
Marquardt RR, Frohlich AA. Rapid reversed-phase high performance liquid chromatographic method for the quantitation of vicine, convicine, and related compounds. J Chromatogr 1981;208:373-9.
Zhang H, Wang Y, Zhang X, Liu M, Hu Z. Analysis of vicine in bitter melon with high performance liquid chromatography. Anal Lett 2003;36:1597-605.
Haixia Z, Xiaozuo Z, Yawei W, Mancanq L, Zhide H. Analysis of vicine in bitter melon samples by polyglycol-C8 solid phase with high performance liquid chromatography. Chin J Anal Chem 2004;3:408.
Sethi PD. High Performance Thin Layer Chromatography. 1st ed. New Delhi: CBS Publishers and Distributors; 1996. p. 4-28.
Stahl E. Thin Layer Chromatography. A Laboratory Hand Book. 2nd ed. Berlin: Springer-Verlag; 1969. p. 5.
Wagner H, Baldt S, Zgainski EM. Plant Drug Analysis. Berlin: Springer; 1996. p. 230.
Meena AK, Narasimhaji CV, Velvizhi D, Singh A, Rekha P, Kumar V, et al
. Determination of gallic acid in ayurvedic polyherbal formulation Triphala churna and its ingredients by HPLC and HPTLC. Res J Pharm Technol 2018;11:3243-9.
Wang JC, Zhang Q, Cai DF. Stability-indicating validated HPLC method for analysis of berberine hydrochloride and trimethoprim in pharmaceutical dosage form. J Chem 2013;2013:1-9.
Sakinala P, Sreelakshmi GSS,Velivela R, Doppalapudi KK, Reddy JS, Reddy Y. RP-HPLC method development and validation for estimation of berberine in bulk and pharmaceutical dosage forms. IJRAR 2019;6:357-68.
Chaudhary P, Patel HU. RP-HPLC and spectrophotometric determination of rutintrihydrate, berberine chloride and trigonelline hydrochloride in antidiabetic polyherbal formulations. Res J Pharm Technol 2020;13:3293-329.
Meena AK, Rekha P, Perumal A, Gokul M, Swathi KN, Ilavarasan R. Estimation of Withaferin-A by HPLC and standardization of the Ashwagandhadi lehyam formulation. Heliyon 2021;7:e06116.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]
[Table 1], [Table 2]